Research & Development
Rome Therapeutics raises $72M in series B financing
Biotech company Rome Therapeutics has raised a further $72 million in financing to develop medicines for autoimmune diseases and continue its exploration of the “dark genome.”
September 20, 2023
Twist Bioscience, Ono Pharmaceutical to collaborate on autoimmune disease drug development
Synthetic biology and genomics company Twist Bioscience has entered into a collaboration with Ono Pharmaceutical, one of the largest pharmaceutical companies in Japan, to discover and develop drugs for autoimmune diseases.
September 5, 2023
Microbiome analysis reveals signatures of arthritic conditions in human gut
The analysis revealed changes to the microbiome in people with inflammatory arthritis conditions. Oral, proinflammatory, and mucin-degrading microbes were enriched in these patients at the expense of some organisms typically found in the human gut.
August 4, 2023
Screening newborns for severe combined immunodeficiency saves lives, study finds
In a study, widespread screening and early treatment of newborn babies with severe combined immunodeficiency boosted their five-year survival rate from 73% to 87%.
June 21, 2023
COVID-19’s 'long tail' analyzed at European rheumatology congress
EULAR’s 2023 Congress includes presentations on iRD patients’ susceptibility to long COVID, and COVID-19 vaccination safety in pregnant and breastfeeding women with autoimmune disease.
May 31, 2023
Werfen completes $2B acquisition of Immucor, expands presence in specialized diagnostics
Immucor's transfusion and transplant product lines complement Werfen's hemostasis, acute care, and autoimmunity business lines, and expand the parent firm's portfolio of specialized diagnostic products for hospitals and clinical laboratories.
March 15, 2023
Prometheus Biosciences announces $500M stock offering
The San Diego-based biotech company is taking a precision medicine approach for the discovery, development, and commercialization of therapeutic and companion diagnostic products for the treatment of immune-mediated diseases.
December 12, 2022
CRISPR may enable rapid, sensitive test for COVID-19
The device has the potential for use as a diagnostic test at the point of care (POC), according to its developers.
September 26, 2022
DxTerity receives NY authorization for SLE test
The DxTerity test is designed for patients with systemic lupus erythema (SLE), which affects up to one million patients in the U.S.
September 15, 2022
Aptorum provides update on its rapid MDx technology
The technology has been clinically validated in more than 100 patient samples, Aptorum said.
September 14, 2022
Prometheus, Takeda launch prognostic tool for Crohn’s
According to Prometheus, CDPath is a personalized risk assessment tool that can be used in combination with a physician's clinical assessment to evaluate an adult patient's risk for developing serious complications of CD such as bowel strictures, internal penetrating disease, or non-perianal surgery within three years.
September 14, 2022
Nordic touts PRO-C6 biomarker for heart failure clinical trials
In collaboration with Bristol Myers Squibb and the University of Pennsylvania, researchers combined analyses of six independent cohorts of HFpEF patients from around the globe, which are being evaluated with the PRO-C6 biomarker.
September 13, 2022
Page 1 of 9